Investing.com - Bluebird reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Bluebird announced earnings per share of $-0.94 on revenue of $100K. Analysts polled by Investing.com EPS of $-1.13 on revenue of $1M.
Bluebird 's are down 28% and is trading at $6.66 , still down 47.23% from its 52 week high of $12.62 set on Monday, November 8, 2021.
Bluebird shares gained 8.65% to trade at $6.66 in intra-day trade the report.
Bluebird follows other major Healthcare sector earnings this month
Bluebird's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar